$150M Series C: Abridge Healthcare AI (2024)
Key Facts
- Company
- Abridge
- Sector
- Healthcare AI
- Country
- United States
- Round Type
- Series C
- Investors
- Lightspeed, Redpoint, Spark Capital
Funding Round Overview
Abridge announced a Series C round on December 10, 2024 totaling $150,000,000 led by Lightspeed. Medical AI startup Abridge raised $150 million Series C. $150M Series C for medical transcription AI.
Deal Highlights
- Capital involved: $150,000,000.
- Round: Series C.
- Investors: Lightspeed, Redpoint, Spark Capital.
Company and Sector Context
Abridge builds in the healthcare ai sector, one of the most active areas in AI investment today. Based in United States, the company is part of a global wave of startups scaling AI into production across regulated and enterprise environments.
How the Capital Helps
Disclosed details include $150M Series C for medical transcription AI. In healthcare ai, speed to market and access to high-quality talent often determine category leadership.
Competitive Landscape
Funding activity in healthcare ai continues to intensify as incumbents and startups race to ship reliable AI systems. This round signals ongoing investor confidence in differentiated technology and defensible distribution.
Looking Ahead
This funding positions Abridge for continued growth in the healthcare ai landscape. As AI adoption accelerates across industries, deals like this signal where capital and strategic attention are moving next.
Frequently Asked Questions
How much did Abridge raise?
Abridge raised $150,000,000 in Series C announced on December 10, 2024.
Who invested in Abridge's Series C?
The investors in Abridge's Series C include Lightspeed, Redpoint, Spark Capital.
What sector is Abridge in?
Abridge operates in the Healthcare AI sector and is based in United States.